After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...